Discontinued — last reported Q3 '23
Merck & Co. Derivative assets decreased by 34.1% to $324.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 6.1%, from $345.00M to $324.00M. Over 5 years (FY 2020 to FY 2025), Derivative assets shows a downward trend with a -9.2% CAGR.
Fluctuations reflect changes in market conditions and the firm's overall derivative hedging or trading strategy.
This represents the fair value of derivative contracts that are in a gain position for the firm. These instruments are u...
Standard for large financial institutions with significant capital markets operations.
fin_derivative_assets| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $174.00M | $133.00M | $121.00M | $241.00M | $134.00M | $242.00M | $19.00M | $284.00M | $244.00M | $176.00M | $239.00M | $167.00M | $142.00M | $298.00M | $345.00M | $268.00M | $855.00M | $492.00M | $324.00M |
| QoQ Change | — | -23.6% | -9.0% | +99.2% | -44.4% | +80.6% | -92.1% | >999% | -14.1% | -27.9% | +35.8% | -30.1% | -15.0% | +109.9% | +15.8% | -22.3% | +219.0% | -42.5% | -34.1% |
| YoY Change | — | — | — | — | -23.0% | +82.0% | -84.3% | +17.8% | +82.1% | -27.3% | >999% | -41.2% | -41.8% | +69.3% | +44.4% | +60.5% | +502.1% | +65.1% | -6.1% |
We use cookies for analytics. See our Privacy and Cookie Policy.